Search

everythinglearnresearchcommunity

for

Search:↓

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

Lanadelumab greatly reduces hospital visits and angioedema episodes, improving life quality for hereditary angioedema patients.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Baricitinib showed mixed results in treating alopecia areata in children, with some improvement but also side effects.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Baricitinib shows promise for treating alopecia areata with mild side effects.

Upadacitinib effectively treats severe alopecia areata and is safe.

Catharanthus roseus and Schwenckia americana extracts are generally safe but may cause kidney and liver tissue damage.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

Bempikibart may help regrow hair in people with alopecia areata.

Baricitinib is effective and safe for treating alopecia areata.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Spironolactone helps reduce hospital visits and death from heart issues, lowers blood pressure, but has unclear effects on heart failure with normal heart pump function and can cause high potassium and breast enlargement in men.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Janus kinase inhibitors can help children with alopecia areata regrow hair but may have some risks.

Integrating ABI screening in clinics can improve patient care for those at risk of peripheral artery disease.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.